Author

Zhenhong Su

Observed names: Z Su, Zhen-Hong Su

Institution: Hubei Polytechnic University

Observed institution: Hubei Polytechnic University

ORCID: 0009-0009-0011-9910

Observed ORCID: 0009-0009-0011-9910

OpenAlex ID: A5011762386

HDAC-targeting epigenetic modulators for cancer immunotherapy

2024 · Binbin Cheng, Wei Pan, et al. · European Journal of Medicinal Chemistry · 119

Recent Progress in DNA Damage Response-Targeting PROTAC Degraders

2024 · Binbin Cheng, Xiaoting Fei, et al. · Journal of Medicinal Chemistry · 28

Discovery of Small and Bifunctional Molecules Targeting PD-L1/CD73 for Cancer Dual Immunotherapy

2024 · Shuanghu Wang, Zhihua Kong, et al. · Journal of Medicinal Chemistry · 23

Boosting cuproptosis by activating JAK-STAT signaling pathway and synergrtic with interface-enhanced sonodynamic immunotherapy against cancer

2025 · Changhong Zhao, Xinshu Zhu, et al. · Nano Today · 8

Discovery of Novel Heterotricyclic Compounds as DNA-Dependent Protein Kinase (DNA-PK) Inhibitors with Enhanced Chemosensitivity, Oral Bioavailability, and the Ability to Potentiate Cancer Immunotherapy

2024 · Binbin Cheng, Yaru Shi, et al. · Journal of Medicinal Chemistry · 8

Novel imidazo[1,2-a]pyridine-based tubulin polymerization inhibitors: Structure-activity relationships and anti-tumor immune potentiation

2025 · Binbin Cheng, Chao Li, et al. · European Journal of Medicinal Chemistry · 4

Efficient tumor clearance and diversified immunity through neoepitope vaccines and combinatorial immunotherapy

2019 · KL Lee, SC Benz, et al. · immuneACCESS · 2

Chalcone-containing dual-targeting PD-L1/tubulin small molecules: a novel approach for cancer immunotherapy

2026 · Yingxing Zhou, Jingwei Ding, et al. · Frontiers in Pharmacology

Th1-biased iNKT cell agonist-loaded liposomal peptide vaccines synergize with a PD-L1 inhibitor to boost immunotherapy against gastric cancer

2026 · Jing-Jing Du, Lei Chen, et al. · Chemical Communications

Works count: 9

Citation count: 192

H-index: 5

I10-index: 3